Zacks Investment Research on MSN
CONMED stock up post Q4 earnings and revenue beat, gross margin up
CONMED Corporation CNMD delivered adjusted earnings per share (EPS) of $1.43 in the fourth quarter of 2025, up 6.7% year over ...
Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance, or results ...
StockStory.org on MSN
CONMED (NYSE:CNMD) beats Q4 CY2025 sales expectations, stock soars
Medical tech company CONMED (NYSE:CNMD) reported Q4 CY2025 results , with sales up 7.9% year on year to $373.2 million. On ...
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights “Our third quarter results ...
Q4 2025 earnings call recap: sales and EPS growth, GI exit, AirSeal/BioBrace outlook, 2026 revenue & EPS guidance, margins and ...
CONMED (NYSE:CNMD) reported fourth-quarter fiscal 2025 sales of $373.2 million, representing a 7.9% year-over-year increase ...
Detailed price information for C O N M E D Corp (CNMD-N) from The Globe and Mail including charting and trades.
NEW YORK (Reuters) - Activist investor Voce Capital Management LLC is pushing ConMed Corp (NSQ:CNMD) to pursue a sale, saying it believes the surgical-device maker could attract buyout interest from ...
We think that DENTSPLY stock (NASDAQ: XRAY), a dental equipment company, is currently a better pick than ConMed (NASDAQ: CNMD), a medical devices company that specializes in products for orthopedic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results